Patents Assigned to The Jiang Cell Biomedical Research Co., Ltd.
  • Patent number: 7897820
    Abstract: A process for preparing Erianin (Dihydro Combretastation A-4), wherein 3,4,5-trimethoxy benzaldehyde is converted to phosphonium salt or phosphonate ester or the likes thereof, then reacted with isovanillin (3-hydroxyl-4-methoxyl benzaldehyde) including a protected hydroxyl in the 3-position, followed by hydrogenation and deprotection.
    Type: Grant
    Filed: July 12, 2006
    Date of Patent: March 1, 2011
    Assignee: Zhe Jiang Cell Biomedical Research Co., Ltd.
    Inventors: Yiping Li, Shuangxi Liu
  • Publication number: 20080306028
    Abstract: This invention relates to a kind of Erianin salt and the preparing process thereof. The said Erianin salt is a compound with the following general formula (I), wherein R is the salt formed by monobasic acid radical of inorganic oxacid combining with metals, ammonium salts, organic amine. This invention also relates to a pharmaceutical composition comprising Erianin salt. Compared with Erianin, the said Erianin salt has far better solubility, which can improve the bioavailability and show better antineoplastic efficacy.
    Type: Application
    Filed: August 1, 2006
    Publication date: December 11, 2008
    Applicant: The Jiang Cell Biomedical Research Co., Ltd.
    Inventors: Yiping Li, Ning Li
  • Publication number: 20080233208
    Abstract: This invention relates to a use of the compound of formula (I), Erianin, in preparing pharmaceutical for treating tumors
    Type: Application
    Filed: January 31, 2008
    Publication date: September 25, 2008
    Applicant: The Jiang Cell Biomedical Research Co., Ltd.
    Inventors: Yiping Li, Ning Li, Danping Zhou, Lizuan Chen
  • Publication number: 20080234369
    Abstract: This invention relates to a compound of formula (I), 3,4,5,4?-tetramethoxyl-?,?-diphenylethane-3?-O-sodium sulphate, and its use in the preparation of antineoplastic pharmaceutical.
    Type: Application
    Filed: January 31, 2008
    Publication date: September 25, 2008
    Applicant: The Jiang Cell Biomedical Research Co., Ltd.
    Inventors: Yiping Li, Ning Li, Danping Zhou, Lizuan Chen